Final programme - eshre 2013

More documents

Recommendations

Info

COURSE 11Sunday, 7 July−−Room Capital Suite 02−−−−Responsible innovation in medically assisted reproductionOrganised by the Special Interest Groups Ethics and Law & Safety and Quality in ARTCourse coordinators: Wybo Dondorp (The Netherlands), Guido De Wert (The Netherlands), Petra De Sutter(Belgium) and Willianne Nelen (The Netherlands)Aim: To present an overview of issues, challenges and responsibilities relevant to the safety and quality of innovationsin medically assisted reproduction.Background: Also in the light of reported subtle health effects in children born with the help of reproductivetechnologies, there is a growing awareness in the field that safety as a crucial aspect of innovation needs moresystematic attention than it has sometimes received in the past. Relevant questions include (but are not limited to) therelation between practice adaption and research, the usefulness of research in animal models and embryos, theimportance of registries and follow-up studies, the level of risk that should be regarded as acceptable and how thevarious stakeholders (including ESHRE) can contribute to making the field more accountable in this regard.Target audience: Congress participants who as researchers, embryologists or clinicians have a professional interestin the safety and quality of new reproductive technologies, participants with a general interest in the ethics of assistedreproduction, policy makers, etc.Course type: AdvancedCourse <strong>programme</strong>Chairman: Willianne Nelen (The Netherlands)09.00 - 09.30 Possible subtle adverse health outcomes of medically assisted reproduction (MAR): a review -Arianna D’Angelo (United Kingdom)09.30 - 09.45 Discussion09.45 - 10.15 Innovation in MAR: lessons from the past (ICSI), challenges for the present (oocyte vitrification),perspectives on the future (artificial gametes) - Heidi Mertes (Belgium)10.15 - 10.30 Discussion10.30 - 11.00 Coffee break11.00 - 11.30 What animal research may contribute to safety and quality in MAR? - Thomas D’Hooghe (Belgium)11.30 - 11.45 Discussion11.45 - 12.15 In vitro-maturation of oocytes: is there a case for preclinical embryo research? -Guido De Wert (The Netherlands)12.15 - 12.30 Discussion12.30 - 13.30 Lunch Chairman: Veerle Provoost (Belgium)13.30 - 14.00 When should practice adaptation be research? The case of culture media in IVF -John Dumoulin (The Netherlands)14.00 - 14.15 Discussion14.15 - 14.45 The health of the future child: what level of risk is acceptable in MAR? -Nils-Eric Sahlin (Sweden)14.45 - 15.00 Discussion15.00 - 15.30 Coffee break15.30 - 16.00 Registries and follow-up studies: a joint responsibility of the field - Maryse Bonduelle (Belgium)44
PRE-CONGRESS COURSES16.00 - 16.15 Discussion16.15 - 16.45 Multidisciplinary forum debate aimed at formulating policy conclusions -Petra De Sutter (Belgium)16.15 - 16.45 Multidisciplinary forum debate aimed at formulating policy conclusions -Wybo J. Dondorp (The Netherlands)16.45 - 17.00 DiscussionProgramme book45
Page 1:
London - United Kingdom 7 to 10 Jul
Page 9 and 10: Contents007 Welcome009 Committees01
Page 11: Session 48:Session 49:Session 50:Se
Page 18 and 19: Committee of National Representativ
Page 23 and 24: GENERAL INFORMATION−−Political
Page 25 and 26: Greater London is served by 12 Tube
Page 27: GENERAL INFORMATIONProgramme book17
Page 32 and 33: Monday 8 July 201308.00 - 17.30 IFF
Page 35 and 36: Agenda of the 2013 Annual GeneralAs
Page 37: AGENDAProgramme book25
Page 41: SOCIAL PROGRAMMEOpening Ceremony an
Page 44 and 45: COURSE 1Sunday, 7 July−−Room Ca
Page 46 and 47: Chairman: Willem Ombelet (Belgium)1
Page 48 and 49: New thoughtsChairman: Mariette Godd
Page 52 and 53: COURSE 7Sunday, 7 July−−−−
Page 60 and 61: course 12Sunday, 7 July−−Room C
Page 62 and 63: Course 13Sunday, 7 July−−Room C
Page 64 and 65: course 15Sunday, 7 JulyRoom Capital
Page 66 and 67: Overview MONDAY, 8 July 201308.00 -
Page 68 and 69: Monday 8 July 2013Invited session08
Page 70 and 71: Monday 8 July 2013Selected oral com
Page 80 and 81: Monday 8 July 2013Company symposium
Page 92 and 93: Overview TUESDAY, 9 July 201308.30
Page 94 and 95: Tuesday 9 July 2013Invited session0
Page 98 and 99: Tuesday 9 July 2013Selected oral co
Page 104 and 105: Tuesday 9 July 2013Company symposiu
Page 108 and 109:
Tuesday 9 July 2013Company symposiu
Page 110 and 111:
Tuesday 9 July 2013Invited session1
Page 112 and 113:
Tuesday 9 July 2013Invited session1
Page 114 and 115:
Tuesday 9 July 2013Selected oral co
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Overview Wednesday, 10 July 201308.
Page 128 and 129:
Wednesday 10 July 2013Invited sessi
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Wednesday 10 July 2013Selected oral
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
136
Page 152 and 153:
Tuesday, 10 July13.00 P-050 Health
Page 154 and 155:
POSTERSAndrologyP-001 Magnetic Acti
Page 156 and 157:
P-028 Female age and number of retr
Page 158 and 159:
P-054 Genomic rearrangements and CN
Page 160 and 161:
P-079 A modified cryotop vitrificat
Page 162 and 163:
P-109 Effect of early blastomere mu
Page 164 and 165:
P-138 Cyclin E1 as a new ICM marker
Page 166 and 167:
P-167 Single medium culture in a ti
Page 168 and 169:
P-196 Early cleaving mouse embryos
Page 170 and 171:
P-225 Luteal phase support has a be
Page 172 and 173:
P-252 Correlation of histomorpholgy
Page 174 and 175:
P-283 Homologous intrauterine insem
Page 176 and 177:
P-310 Uterine contraction after emb
Page 178 and 179:
Paramedical - laboratoryP-335 To en
Page 180 and 181:
P-363 Effects of pharmacologically
Page 182 and 183:
P-393 "It is not his child, it is o
Page 184 and 185:
P-420 Differences in somatic cell g
Page 186 and 187:
P-446 Comparison between fresh or v
Page 188 and 189:
P-475 Use of ovarian reserve parame
Page 190 and 191:
P-503 Low follicular fluid tyrosine
Page 192 and 193:
P-531 Addition of luteal estradiol
Page 194 and 195:
P-557 Altered sensitivity rather th
Page 196 and 197:
P-585 A late presentation of obstru
Page 198 and 199:
184
Page 200 and 201:
Anastácio A. 60Andersen A.N. 80And
Page 202 and 203:
Bowman N. 55, 153Boyer P. 147Bozdag
Page 204 and 205:
Critchley H.O.D. 167Crivello A.M. 1
Page 206 and 207:
Farrag A. 143Farreras A. 149, 150Fa
Page 208 and 209:
Guarneri C. 143Gudi A. 57Guérif F.
Page 210 and 211:
Izzi-Engbeaya C. 177Izzo C.R. 148JJ
Page 212 and 213:
Kuchenbecker W.K.H. 182Kuchiki M. 1
Page 214 and 215:
Makedos A. 179Makyan Z. 134Malcov M
Page 216 and 217:
Nascimento A.M. 58, 73, 143,160, 17
Page 218 and 219:
Piccinini C.A. 166Piccolomini M. 17
Page 220 and 221:
Sanad A. 182Sanchez A.M. 158Sánche
Page 222 and 223:
Surlan L. 152, 164Sutcliffe A.G. 10
Page 224 and 225:
Velthut-Meikas A. 170Veltman D.J. 5
Page 226 and 227:
Zervomanolakis I. 87Zeyneloglu H.B.
Page 228:
Achevé d’imprimer par :
show all

Final programme - eshre 2013

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?